160 related articles for article (PubMed ID: 32426277)
1. A Simple Model Established by Blood Markers Predicting Overall Survival After Radical Resection of Pancreatic Ductal Adenocarcinoma.
Zhang LX; Chen L; Xu AM
Front Oncol; 2020; 10():583. PubMed ID: 32426277
[No Abstract] [Full Text] [Related]
2. Comparison and validation of the value of preoperative inflammation marker-based prognostic scores in resectable pancreatic ductal adenocarcinoma.
Ye S; Bai L
Cancer Manag Res; 2018; 10():3405-3417. PubMed ID: 30237742
[TBL] [Abstract][Full Text] [Related]
3. Model established based on blood markers predicts overall survival in patients after radical resection of types II and III adenocarcinoma of the esophagogastric junction.
Wei ZJ; Qiao YT; Zhou BC; Rankine AN; Zhang LX; Su YZ; Xu AM; Han WX; Luo PQ
World J Gastrointest Surg; 2022 Aug; 14(8):788-798. PubMed ID: 36157366
[TBL] [Abstract][Full Text] [Related]
4. Independent effect of postoperative neutrophil-to-lymphocyte ratio on the survival of pancreatic ductal adenocarcinoma with open distal pancreatosplenectomy and its nomogram-based prediction.
Pu N; Yin H; Zhao G; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
J Cancer; 2019; 10(24):5935-5943. PubMed ID: 31762803
[No Abstract] [Full Text] [Related]
5. Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection.
Tong J; Jiang W; Mao S; Wu S; Lu C
Front Oncol; 2022; 12():1040411. PubMed ID: 36479089
[TBL] [Abstract][Full Text] [Related]
6. A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection.
He C; Sun S; Zhang Y; Lin X; Li S
Front Oncol; 2020; 10():1564. PubMed ID: 33014805
[TBL] [Abstract][Full Text] [Related]
7. Prediction of overall survival after radical gastrectomy using nomograms created by tumor markers.
Zhang LX; Cao ZY; Li HH; Li CH; Li AQ; Luo PQ; Song ED; Wei ZJ; Han WX; Su YZ; Ye LP; Xu AM
J Investig Med; 2023 Oct; 71(7):782-790. PubMed ID: 37477004
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of pre-treatment peripheral blood markers in pancreatic ductal adenocarcinoma and their association with S100A4 expression in tumor tissue.
Li H; Tian X; Xu Y; Pan Y; Huang Y; Zhou D; Song Z
Oncol Lett; 2019 Nov; 18(5):4523-4534. PubMed ID: 31611961
[TBL] [Abstract][Full Text] [Related]
9. Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection.
Pu N; Gao S; Xu Y; Zhao G; Lv Y; Nuerxiati A; Li JA; Wang D; Xu X; Kuang T; Wang X; Lou W; Liu L; Wu W
J Cancer; 2017; 8(16):3362-3370. PubMed ID: 29158809
[No Abstract] [Full Text] [Related]
10. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of CONUT score combined with serum CA199 levels in postoperative survival of patients with pancreatic ductal adenocarcinoma: a retrospective study.
Wang A; Sun B; Wang M; Shi H; Huang Z; He T; Li Q; Deng J; Fu W; Jiang Y
PeerJ; 2020; 8():e8811. PubMed ID: 32219033
[TBL] [Abstract][Full Text] [Related]
12. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
[TBL] [Abstract][Full Text] [Related]
13. Perioperative lymphocyte-to-monocyte ratio changes plus CA199 in predicting the prognosis of patients with gastric cancer.
Zhu Y; Zhao W; Mao G
J Gastrointest Oncol; 2022 Jun; 13(3):1007-1021. PubMed ID: 35837178
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Inflammation-based Model in Advanced Pancreatic Ductal Adenocarcinoma.
Wu LX; Wang XY; Xu KQ; Lin YL; Zhu WY; Han L; Shao YT; Zhou HY; Jiang H; Hang JJ; Yang XG
J Cancer; 2019; 10(26):6673-6680. PubMed ID: 31777596
[TBL] [Abstract][Full Text] [Related]
15. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma.
Abe T; Amano H; Kobayashi T; Hanada K; Nakahara M; Ohdan H; Noriyuki T
Eur J Surg Oncol; 2018 Oct; 44(10):1573-1579. PubMed ID: 29807728
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a novel nomogram for predicting the prognosis of patients with resected pancreatic adenocarcinoma.
Ren H; Wu CR; Aimaiti S; Wang CF
Oncol Lett; 2020 Jun; 19(6):4093-4105. PubMed ID: 32382348
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Effect of Age in Resected Pancreatic Cancer Patients: A Propensity Score Matching Analysis.
Xu Y; Zhang Y; Han S; Jin D; Xu X; Kuang T; Wu W; Wang D; Lou W
Front Oncol; 2022; 12():789351. PubMed ID: 35433408
[TBL] [Abstract][Full Text] [Related]
18. A sample model established by S-index predicting overall survival after curative resection of primary hepatocellular carcinoma.
Chen L; Cai BB; Zhou CJ; Hou XQ; Hu SP; Fang G; Chen WC; Li LH; Yang WJ
Cancer Manag Res; 2019; 11():693-703. PubMed ID: 30679923
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Nomogram Based on Nutritional Indicators and Tumor Markers for Prognosis Prediction of Pancreatic Ductal Adenocarcinoma.
Li H; Zhou F; Cao Z; Tang Y; Huang Y; Li Y; Yi B; Yang J; Du P; Zhu D; Zhou J
Front Oncol; 2021; 11():682969. PubMed ID: 34136406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]